Eli Lilly Invests $6B in Alabama Plant for Obesity Pill

Eli Lillys six billion dollar investment in Alabama will boost production of its experimental obesity pill and other medications, creating 450 new jobs and 3000 construction jobs. This move underscores the companys commitment to expanding U.S. manufacturing capabilities and strengthening supply chains.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.